Cargando…

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease

BACKGROUND: Lung disease as major cause for morbidity in patients with cystic fibrosis (CF) starts early in life. Its large phenotypic heterogeneity is partially explained by the genotype but other contributing factors are not well delineated. The close relationship between mucus, inflammation and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steinke, Eva, Sommerburg, Olaf, Graeber, Simon Y., Joachim, Cornelia, Labitzke, Christiane, Nissen, Gyde, Ricklefs, Isabell, Rudolf, Isa, Kopp, Matthias V., Dittrich, Anna-Maria, Mall, Marcus A., Stahl, Mirjam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853074/ https://www.ncbi.nlm.nih.gov/pubmed/36687447 http://dx.doi.org/10.3389/fmed.2022.1034290

Ejemplares similares

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
por: Metzger, Marisa I., et al.
Publicado: (2021)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
por: Frey, Dario L., et al.
Publicado: (2022)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
por: Berges, Julian, et al.
Publicado: (2023)

Two Beer(s) or Not Two Beer(s): The eNose as an Instrument to Pacify the World
por: Kopp, Matthias Volkmar, et al.
Publicado: (2022)

Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis—implications for process quality and patient care
por: Gramer, Gwendolyn, et al.
Publicado: (2020)

Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases
por: Stahl, Mirjam, et al.
Publicado: (2020)

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis
por: Stahl, Mirjam, et al.
Publicado: (2021)

Supplementation with Red Palm Oil Increases β-Carotene and Vitamin A Blood Levels in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2015)

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis
por: Leutz-Schmidt, Patricia, et al.
Publicado: (2023)

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2017)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
por: Wucherpfennig, Lena, et al.
Publicado: (2023)

Reply to Dournes et al.: Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis
por: Stahl, Mirjam, et al.
Publicado: (2021)

Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial
por: Stahl, Mirjam, et al.
Publicado: (2023)

A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF
por: Thee, Stephanie, et al.
Publicado: (2021)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2021)

Increased Inflammatory Markers Detected in Nasal Lavage Correlate with Paranasal Sinus Abnormalities at MRI in Adolescent Patients with Cystic Fibrosis
por: Chung, Jaehi, et al.
Publicado: (2021)

Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses
por: Sommerburg, Olaf, et al.
Publicado: (2020)

Inquilinus limosus in Patients with Cystic Fibrosis, Germany
por: Wellinghausen, Nele, et al.
Publicado: (2005)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
por: Piehler, Linus, et al.
Publicado: (2023)

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2021)

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2015)

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2014)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2023)

Stochastic Tracking of Infection in a CF Lung
por: Zarei, Sara, et al.
Publicado: (2014)

Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study
por: Thee, Stephanie, et al.
Publicado: (2022)

The value of chest magnetic resonance imaging compared to chest radiographs with and without additional lung ultrasound in children with complicated pneumonia
por: Konietzke, Philip, et al.
Publicado: (2020)

In vitro neutrophil migration is associated with inhaled corticosteroid treatment and serum cytokines in pediatric asthma
por: Lemmel, Solveig, et al.
Publicado: (2022)

68 Respiratory viral detection in children with cystic fibrosis (CF)
por: Tješić-Drinković, I., et al.
Publicado: (2015)

Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis
por: Rademacher, Jessica, et al.
Publicado: (2023)

The human respiratory tract microbial community structures in healthy and cystic fibrosis infants
por: Pust, Marie-Madlen, et al.
Publicado: (2020)

Rehabilitation Programs for Cystic Fibrosis – View from a CF Center
por: Griese, M, et al.
Publicado: (2010)

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas
por: Evans, Ieuan E. S., et al.
Publicado: (2023)

Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study
por: Goss, Christopher H., et al.
Publicado: (2022)

Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis
por: De, Hriday, et al.
Publicado: (2016)

1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
por: Edwards, Brett, et al.
Publicado: (2018)

Oral Hygiene and Periodontal Treatment Needs in Adult Patients with Cystic Fibrosis (CF)
por: Hildebrandt, Tomasz, et al.
Publicado: (2022)

Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2023)

Analysis of CF patient survival confirms STAT3 as a CF-modifying gene with changing impact over time
por: Dunsche, Inga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r2iraopefrubuos5gklfnfiqfa